The University is one of the world’s oldest universities and leading academic centres, and a self-governed community of scholars. Its reputation for outstanding academic achievement is known worldwide and reflects the intellectual achievement of its students, as well as the world-class original research carried out by the staff of the University and the Colleges.
UCAM will serve as the clinical data centre for IDEA-FAST, facilitate study management and support data processing and analysis. In parallel, a patient-facing data portal will be constructed, allowing patients to enter data directly as appropriate.
UCAM will also provide expertise in the measurement of depression, anxiety and other behavioural symptoms in people with IBD and other chronic inflammatory disease
Target recruitment:
• Inflammatory Bowel Disease – 50
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.